Muna Bhanji

Insider Reports History

Entity
Individual
Location
C/O Cytokinetics, Incorporated, 280 East Grand Avenue, South San Francisco, CA
Signature
/s/ James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Muna Bhanji:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CYTOKINETICS INC Director Common Stock 17.6K $918K $52.07 Jun 10, 2024 Direct
VERACYTE, INC. Director Common Stock 34.6K $712K $20.59 Jun 13, 2024 Direct
Intellia Therapeutics, Inc. Director Common Stock 19.5K $194K $9.97 Jan 29, 2025 Direct
CYTOKINETICS INC Director Non-Qualified Stock Option (Right to Buy) 3.64K $152K $41.69 May 15, 2024 Direct
ARDELYX, INC. Director Stock Option (Right to Buy) 40.2K $93.4K $2.32 Jun 14, 2024 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11.5K Jun 12, 2024 Direct

Insider Reports Filed by Muna Bhanji

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Jan 29, 2025 1 -$2.64K 4 Jan 31, 2025 Director
ARDX ARDELYX, INC. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
VCYT VERACYTE, INC. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
NTLA Intellia Therapeutics, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
VCYT VERACYTE, INC. Jun 10, 2024 1 -$78.6K 4 Jun 11, 2024 Director
CYTK CYTOKINETICS INC Jun 10, 2024 1 -$104K 4 Jun 10, 2024 Director
VCYT VERACYTE, INC. May 28, 2024 1 -$32.3K 4 May 30, 2024 Director
CYTK CYTOKINETICS INC May 15, 2024 2 $0 4 May 16, 2024 Director
NTLA Intellia Therapeutics, Inc. Oct 31, 2023 1 -$6.33K 4 Nov 2, 2023 Director
NTLA Intellia Therapeutics, Inc. Jul 31, 2023 1 -$11.2K 4 Aug 2, 2023 Director
CYTK CYTOKINETICS INC Jul 7, 2023 1 -$68.2K 4 Jul 7, 2023 Director
NTLA Intellia Therapeutics, Inc. Jul 6, 2023 1 -$73.4K 4 Jul 10, 2023 Director
VCYT VERACYTE, INC. Jun 16, 2023 2 -$156K 4 Jun 21, 2023 Director
ARDX ARDELYX, INC. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
VCYT VERACYTE, INC. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
VCYT VERACYTE, INC. May 30, 2023 1 -$39.9K 4 Jun 1, 2023 Director
CYTK CYTOKINETICS INC May 10, 2023 2 $0 4 May 18, 2023 Director
CYTK CYTOKINETICS INC Oct 3, 2022 1 $11.2K 4 Oct 5, 2022 Director
CYTK CYTOKINETICS INC Jul 1, 2022 1 $11.2K 4 Jul 12, 2022 Director
VCYT VERACYTE, INC. Jun 16, 2022 1 $0 4 Jun 16, 2022 Director
ARDX ARDELYX, INC. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
NTLA Intellia Therapeutics, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
CYTK CYTOKINETICS INC May 10, 2022 2 $0 4 May 11, 2022 Director
NTLA Intellia Therapeutics, Inc. Apr 28, 2022 2 $0 4 May 2, 2022 Director
NTLA Intellia Therapeutics, Inc. Apr 28, 2022 0 $0 3 May 2, 2022 Director
CYTK CYTOKINETICS INC Apr 1, 2022 1 $11.2K 4 Apr 1, 2022 Director
CYTK CYTOKINETICS INC Jan 3, 2022 1 $11.2K 4 Jan 4, 2022 Director
CYTK CYTOKINETICS INC May 12, 2021 2 $0 4 May 13, 2021 Director